3136 results for «2889»
3136 results
TAVI durability: important considerations for patient lifetime management
18 May 2022 – From EuroPCR 2022
Managing acute coronary perforation: a simulation-based team approach
18 May 2022 – From EuroPCR 2022
IVUS and OCT: when, how, why?
18 May 2022 – From EuroPCR 2022
Streamlined TAVI with Tokyo Live @EuroPCR
19 May 2022 – From EuroPCR 2022
Watch the live case from Milan, Italy, of an 88-year-old female patient with hypertension who was admitted for dyspnoea with discovery of severe aortic stenosis to consider state-of-the-art TAVI.
How should I treat ostial circumflex restenosis?
19 May 2022 – From EuroPCR 2022
Consider how to treat circumflex restenosis after a left main crossover stent and circumflex restenosis after left main PCI with 2 stents and try to learn from the two cases presented in this session: what are the ostial circumflex restenosis mechanisms, and the treatment options? What...
Transcatheter mitral valve replacement
18 May 2022 – From EuroPCR 2022
In this session focusing on transcatheter mitral valve replacement, learn more about: who are the optimal patients, two clinical case examples - "meet the patient" and "a live CT analysis", and what to analyse and measure during the CT analysis.
EuroPCR 2022 Andreas Grüntzig Ethica Award
19 May 2022 – From EuroPCR 2022
This award is an opportunity to highlight and thank nurses and allied professionals from all around the world for their unwavering commitment and outstanding skills, and to honour those who have been especially recognised during the Covid-19 pandemic.
Image-guided bifurcation stenting - In vitro beating heart simulation-based learning from Japan
18 May 2022 – From EuroPCR 2022
The focus of this EuroPCR 2022 session is on complex bifurcation intervention: learn a step-wise approach using imaging in a bifurcation stenting strategy, acknowledge the geographical differences in the way we approach these techniques, and experience the use of simulation-based learning on an in vitro beating...
Secondary mitral regurgitation: when and how to treat
19 May 2022 – From EuroPCR 2022
Watch a 46-year-old patient from Toulouse presenting a congestive heart failure syndrome with a severe secondary mitral regurgitation being treated live!
HighLife TSMVR and their latest experiences, moving forward
29 Nov 2022 – From PCR London Valves 2022
A panel of experts review the latest clinical data, study progress and future plans regarding mitral valve replacement, and the position of HighLife, a new technology in this field.
Create the future of TAVI - Optimisation of the procedure and patient pathway
27 Nov 2022 – From PCR London Valves 2022
Dive into this session to discover what can be improved today to be ready to treat future TAVI patient volumes. You'll also learn how to set up a successful TAVI coordinating team and adopt it in your hospital, and how to create a win-win partnership with...
Twenty years of progress - What we have achieved - LIVE case
27 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI by axillary access (Live)
An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
Remaining unmet needs and strategies in TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this session to understand why valve design impacts future patient outcomes and how hemodynamics can impact decision-making and the durability of the TAVI devices. At the end of the session, you'll also get an overview of Medtronic's portfolio.
TAVI step by step: from femoral puncture to procedural success
27 Nov 2022 – From PCR London Valves 2022
Look at these presentations to get insights into the basics of CT evaluation for TAVI procedural planning, and discover how to optimise every aspect of the TAVI procedure and ensure the best clinical outcomes even in difficult anatomies.
Technical challenges and optimal device choice for complex TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Learn how to anticipate the risks of a valve-in-valve procedure in small surgical prostheses, and discover the latest technological evolutions for treating patients with complex anatomy.
Innovations in TMVR and Intrepid trial updates
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to gain insights on the APOLLO TMVR trial, the Intrepid trial and to hear about future innovations in mitral replacement.
Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up
27 Nov 2022 – From PCR London Valves 2022
Consult these presentations to learn more about tricuspid valve intervention in heart failure patients, to discover which patients are suitable candidates for this procedure and to appreciate the importance of imaging, haemodynamic assessment, optimised medical and heart rhythm treatment prior to this intervention.
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
TAVI complications: Session 1
27 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of challenging TAVI complications cases: an annular rupture after TAVI in a bicuspid aortic valve, an outflow tract rupture during self-expandable transcatheter valve implantation, a periprocedural TAVI ischaemic stroke, and more!
Rapid-fire abstracts: session 1
27 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!
